Please assess the completion status of the following clinical trial:

Trial Title: The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Be a licensed driver.~* Need to have acuity of 20/40 or better, with or without correction on a Snellen Visual Acuity eye chart.~Exclusion Criteria:~* At the discretion of the examining physician, individuals with significant cardiovascular, hepatic or renal disease, uncontrolled hypertension, and chronic pulmonary disease (eg, asthma, COPD) will be excluded.~* Unwillingness to abstain from cannabis for 2 days prior to screening and experimental visits~* Positive pregnancy test~* A positive result on toxicity screening for cocaine, amphetamines, opiates, and phencyclidine (PCP) will exclude individuals from participation.~* Unwilling to refrain from driving or operating heavy machinery for four hours after consuming study medication.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Placebo Cannabis (Type: PLACEBO_COMPARATOR): Subjects will smoke cannabis with placebo THC (.02%) ad libitum
- Cannabis with 5.9% THC (Type: EXPERIMENTAL): Subjects will smoke cannabis cigarettes with 5.9% THC ad libitum
- Cannabis with 13.4% THC (Type: EXPERIMENTAL): Subjects will smoke cannabis cigarettes with 13.4% THC ad libitum

Based on this trial design, predict the completion outcome and termination type (if applicable).